News Image

Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting

Provided By GlobeNewswire

Last update: Mar 25, 2025

Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001

Erasca will also present potential first-in-class examples of direct SMP complex inhibitors, representing a new approach to block the RAS/MAPK pathway

Read more at globenewswire.com

ERASCA INC

NASDAQ:ERAS (7/23/2025, 8:20:01 PM)

After market: 1.71 0 (0%)

1.71

+0.03 (+1.79%)



Find more stocks in the Stock Screener

Follow ChartMill for more